natgillin/translations-raw huggingface dataset:
Hver 49 mg/51 mg filmovertrukken tablet indeholder 48,6 mg sacubitril og 51,4 mg valsartan (sacubitril-valsartan-som natriumsaltkompleks).
Each 49 mg/51 mg film-coated tablet contains 48.6 mg sacubitril and 51.4 mg valsartan (as sacubitril valsartan sodium salt complex).
Hver 49 mg/51 mg tablet indeholder 48,6 mg sacubitril og 51,4 mg valsartan (som sacubitril-valsartan- natriumsaltkompleks).
Each 49 mg/51 mg tablet contains 48.6 mg sacubitril and 51.4 mg valsartan (as sacubitril valsartan sodium salt complex).
Hver 5 mg fyldte orale sprøjte indeholder 5 mg midazolam (som hydrochlorid) i 1 ml mundhulevæske.
Each 5 mg pre-filled oral syringe contains 5 mg midazolam (as hydrochloride) in 1 ml solution.
Hver 5 mg smeltetablet indeholder 47,5 mg lactose (som monohydrat), 0,2625 mg saccharose og 2,25 mg aspartam (E951).
Each 5 mg orodispersible tablet contains 47.5 mg of lactose (as monohydrate) 0.2625 mg of sucrose and 2.25 mg of aspartame (E951).
Hver 5 mg tablet indeholder 63 mg lactose (som monohydrat).
Each 5 mg tablet contains 63 mg lactose (as monohydrate).
Hver 5 ml hætteglas indeholder 50 mg brivaracetam.
Each 5 ml vial contains 50 mg brivaracetam
Hver 50 mg filmovertrukken tablet indeholder 189 mg lactose.
Each 50 mg film-coated tablet contains 189 mg lactose.
Hver 500 mg filmovertrukket tablet indeholder 52 mg lactose, vandfri.
Each 500 mg film-coated tablet contains 52 mg anhydrous lactose.
Hver 56-styksforpakning indeholder en Turbospin-pulverinhalatorenhed og 7 blisterpakninger med 8 kapsler eller en Turbospin-pulverinhalatorenhed og 4 blisterpakninger med 14 kapsler (56 hårde kapsler) tilstrækkeligt til 4 ugers anvendelse.
Each 56 capsule pack contains one Turbospin powder inhaler device and 7 blisters of 8 capsules or one Turbospin powder inhaler device and 4 blisters of 14 capsules (56 hard capsules) sufficient for 4 weeks use.
Hver 6,25 mg tablet indeholder alogliptinbenzoat svarende til 6,25 mg alogliptin.
Each 6.25 mg tablet contains alogliptin benzoate equivalent to 6.25 mg alogliptin
Hver 6. til 8. uge afhæ ngig af din sygdom
Every 6 to 8 weeks depending on your disease
Hver 60 mg daglig dosis består af tre grå 20 mg kapsler.
Each 60 mg daily dose contains three grey 20 mg capsules.
Hver 60 mg tablet indeholder 5,47 mg lactose.
Each 60 mg tablet contains 5.47 mg of lactose.
Hver 60 mg tablet indeholder 60 mg tolvaptan.
Each Jinarc 60 mg tablet contains 60 mg tolvaptan.
Hver 60 mg tablet indeholder ca.
Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Hver 60 ml flaske Rapamune indeholder 60 mg sirolimus
Each 60 mL bottle of Rapamune contains 60 mg sirolimus.
Hver 63 mikrogram fyldt pen indeholder 63 mikrogram peginterferon beta-1a* i 0,5 ml injektionsvæske, opløsning.
Each 63 microgram pre-filled pen contains 63 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Hver 63 mikrogram fyldt sprøjte indeholder 63 mikrogram peginterferon beta-1a* i 0,5 ml injektionsvæske, opløsning.
Each 63 microgram pre-filled syringe contains 63 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Hver 7,5 mg fyldte orale sprøjte indeholder 7,5 mg midazolam (som hydrochlorid) i 1,5 ml mundhulevæske.
Each 7.5 mg pre-filled oral syringe contains 7.5 mg midazolam (as hydrochloride) in 1.5 ml solution.
hver 72. time.
10 mg every 72 hours.
Hver 75 mg filmovertrukken tablet indeholder 283 mg lactose.
Each 75 mg film-coated tablet contains 283 mg lactose.
Hver 8 mg depottablet indeholder 0,525 mg sojalecithin og 58,125 mg lactose.
Each 8 mg prolonged-release tablet contains 0.525 mg of soya lecithin and 58.125 mg of lactose.
Hver 8,8 mikrogram fyldt pen indeholder 8,8 mikrogram interferon beta-1a (2,4 millioner Internationale Enheder (IE)).
Each 8.8 micrograms pre-filled pen contains 8.8 micrograms of interferon beta-1a (2.4 million IU).
Hver 8,8 mikrogram injektionssprøjte indeholder 8,8 mikrogram interferon beta-1a (2,4 millioner Internationale Enheder (IE)).
Each 8.8 micrograms syringe contains 8.8 micrograms of interferon beta-1a (2.4 million IU).
Hver 8-styksforpakning indeholder en Turbospin-pulverinhalatorenhed og 1 blisterpakning med 8 hårde kapsler tilstrækkeligt til 4 dages anvendelse.
Each 8 capsule pack contains one Turbospin powder inhaler device and 1 blister of 8 hard capsules sufficient for 4 days use.
hver 8. uge
be considered
hver 8. uge
every 8 weeks
hver 8. uge
q 8 wks
Hver 8. uge
Vedolizumab Every 8 Weeks
Hver 80 mg kapsel indeholder 80 mg aprepitant.
Each 80 mg hard capsule contains 80 mg of aprepitant.
Hver 90 mg tablet indeholder 8,21 mg lactose.
Each 90 mg tablet contains 8.21 mg of lactose.
Hver 90 mg tablet indeholder 90 mg tolvaptan.
Each Jinarc 90 mg tablet contains 90 mg tolvaptan.
Hver 90 mg tablet indeholder ca.
Each 30 mg tablet contains approximately 70 mg lactose (as monohydrate).
Hver 94 mikrogram fyldt pen indeholder 94 mikrogram peginterferon beta-1a* i 0,5 ml injektionsvæske, opløsning.
Each 94 microgram pre-filled pen contains 94 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Hver 94 mikrogram fyldt sprøjte indeholder 94 mikrogram peginterferon beta-1a* i 0,5 ml injektionsvæske, opløsning.
Each 94 microgram pre-filled syringe contains 94 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Hver 95 mg/23,75 mg kapsel med modificeret udløsning, hård, indeholder 95 mg levodopa og 23,75 mg carbidopa (som monohydrat)
Each 95 mg/23.75 mg modified-release hard capsule contains 95 mg levodopa and 23.75 mg carbidopa (as monohydrate)
Hver 97 mg/103 mg filmovertrukken tablet indeholder 97,2 mg sacubitril og 102,8 mg valsartan (som sacubitril-valsartan-natriumsaltkompleks).
Each 97 mg/103 mg film-coated tablet contains 97.2 mg sacubitril and 102.8 mg valsartan (as sacubitril valsartan sodium salt complex).
Hver 97 mg/103 mg tablet indeholder 97,2 mg sacubitril og 102,8 mg valsartan (som sacubitril- valsartan- natriumsaltkompleks).
Each 97 mg/103 mg tablet contains 97.2 mg sacubitril and 102.8 mg valsartan (as sacubitril valsartan sodium salt complex).
Hver 97 mg/103 mg tablet indeholder 97,2 mg sacubitril og 102,8 mg valsartan (som sacubitril- valsartan-natriumsaltkompleks).
Each 97 mg/103 mg tablet contains 97.2 mg sacubitril and 102.8 mg valsartan (as sacubitril valsartan sodium salt complex).
Hver Aerivio Spiromax inhalator indeholder 60 inhalationer og har en hvid underdel med et halvgennemsigtigt gult låg på mundstykket.
Each Aerivio Spiromax inhaler contains 60 inhalations and has a white body with a semi-transparent yellow mouthpiece cover.
Hver af disse ADR’er opstod én gang.
Each of these ADRs occurred once.
Hver af disse komponenter bidrog til reduktionen i det primære sammensatte endepunkt (CV-dødsfald 17 % RRR, MI 16 % RRR og apopleksi 25 % RRR).
Each of the components contributed to the reduction in the primary composite endpoint (CV death 17% RRR, MI 16% RRR, and stroke 25% RRR).
Hver afgivet dosis indeholder 184 mikrogram fluticasonfuroat og 22 mikrogram vilanterol (som trifenatat).
Each delivered dose contains 184 micrograms of fluticasone furoate and 22 micrograms of vilanterol (as trifenatate).
Hver afgivet dosis indeholder 92 mikrogram fluticasonfuroat og 22 mikrogram vilanterol (som trifenatat).
Each delivered dose contains 92 micrograms of fluticasone furoate and 22 micrograms of vilanterol (as trifenatate).
Hver afmålt dosis (dosen, der kommer ud af mundstykket) indeholder 396 mikrogram aclidiniumbromid (svarende til 340 mikrogram aclidinium) og 11,8 mikrogram formoterolfumaratdihydrat.
Each delivered dose (the dose leaving the mouthpiece) contains 396 micrograms of aclidinium bromide (equivalent to 340 micrograms of aclidinium) and 11.8 micrograms of formoterol fumarate dihydrate.
Hver afmålt dosis indeholder 50 mikrogram salmeterol (som salmeterolxinafoat) og 500 mikrogram fluticasonpropionat.
Each metered dose contains 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms of fluticasone propionate.
Hver afmålte dosis indeholder 50 mikrogram salmeterol (som salmeterolxinafoat) og 500 mikrogram fluticasonpropionat.
Each metered dose contains 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms of fluticasone propionate.
Hver afmålte dosis indeholder 50 mikrogram salmeterol (som salmeterolxinafoat) og 500 mikrogram fluticasonpropionat.
Each metered dose contains 50 micrograms salmeterol (as salmeterol xinafoate) and 500 micrograms fluticasone propionate.
Hver Airexar Spiromax inhalator indeholder 60 inhalationer og har en hvid underdel med et halvgennemsigtigt gult låg på mundstykket.
Each Aerivio Spiromax inhaler contains 60 inhalations and has a white body with a semi-transparent yellow mouthpiece cover.
Hver aktivering medfører afgivelse af 50 mikroliter, som indeholder 7,5 mg lidocain og 2,5 mg prilocain.
Each actuation delivers 50 microlitres which contains 7.5 mg lidocaine and 2.5 mg prilocaine.
Hver aluminiumstube indeholder 2 g gel og har en skruehætte af polyethylen.
Each aluminium tube contains 2 g gel and has a polyethylene screw cap.
Hver AMMONAPS-tablet indeholder 62 mg natrium.
Each AMMONAPS tablet contains 62 mg of sodium.
Hver ampul a 2 ml indeholder 10 mg ibuprofen
Each ampoule of 2 ml contains 10 mg ibuprofen
Hver ampul a 2 ml indeholder 10 mg ibuprofen.
Each 2 ml ampoule contains 10 mg ibuprofen.
Hver ampul indeholder 10 mg arsentrioxid.
Each ampoule contains 10 mg of arsenic trioxide.
Hver ampul indeholder 30 mg alemtuzumab
Each ampoule contains 30 mg of alemtuzumab.
Hver ampul med 2 ml opløsning indeholder 20 mikrogram iloprost (som iloprosttrometamol).
Each ampoule with 2 ml solution contains 20 microgram iloprost.
Hver ampul på 1,7 ml indeholder 170 mg tobramycin.
Each ampoule of 1.7 ml contains 170 mg tobramycin.
Hver anden dag (én gang hver anden dag) indsprøjtes 1,0 ml af den klargjorte Betaferon- injektionsvæske (se tillæg ”Fremgangsmåde, når du selv skal indsprøjte medicinen”, del II, i anden del af denne indlægsseddel) under huden (subkutant).
Every other day (once every two days), 1.0 ml of the prepared Betaferon solution (see Annex ‘Self- injection procedure’ in the second part of this leaflet) injected under the skin (subcutaneously).
Hver anden dag (én gang hver anden dag) indsprøjtes 1,0 ml af den klargjorte Betaferon- injektionsvæske (se tillæg ”Fremgangsmåde, når du selv skal indsprøjte medicinen”, i anden del af denne indlægsseddel) under huden (subkutant).
Every other day (once every two days), 1.0 ml of the prepared Betaferon solution (see Annex ‘Self- injection procedure’ in the second part of this leaflet) injected under the skin (subcutaneously).
Hver anden uge
Every two weeks
hver anden uge i de første 6 måneders behandling, og herefter hver 8. uge (se 4.4).
every two weeks during the first six months of treatment, and every 8 weeks thereafter (see section 4.4).
Hver applikator indeholder:
Each unit dose (applicator) delivers:
Hver behandlingsarm omfattede samme antal behandlingsnaive patienter som patienter, der tidligere var behandlet med cytokiner (53 % og 47 % i pazopanib-armen, 54 % og 46 % i placebo-armen).
A similar proportion of patients in each arm were treatment-naïve and cytokine-pre-treated (53 % and 47 % in pazopanib arm, 54 % and 46 % in placebo arm).
Hver behandlingscyklus består af to Xiapex-injektioner og en procedure for remodellering af penis.
Each treatment cycle consists of two Xiapex injections and one penile modeling procedure.
Hver behandlingsperiode må ikke overstige 4 uger, på grund af manglende doser eller pause i behandlingen.
Each treatment period should not be extended beyond 4 weeks due to missed doses or rest periods.
Hver beholder er pakket i en karton.
Each bottle is packed in a carton.
Hver beholder indeholder 3,8 cm2autologt humant corneaepitel fastgjort på et fibrint underlag og dækket af transportmedium.
Each container contains 3.8 cm2 of autologous human corneal epithelium attached on a fibrin support and covered with transport medium.
Hver beholder indeholder 3,8 cm2autologt humant corneaepitel fastgjort på et fibrint underlag og dækket af transportmedium.
Each container contains 3.8 cm2 of autologous human corneal epithelium attached to a fibrin support and immersed in transport medium.
Hver beholder indeholder en eller to poser med tørremiddel til at holde tabletterne tørre.
Each bottle contains one pouch or two pouches to keep the tablets dry (desiccant).
Hver beholder indeholder enten 30 tabletter eller 350 tabletter.
Each bottle contains either 30 tablets or 350 tablets.
Hver beholder indeholder mindst 20 doser (6,5 ml) eller 12 doser (5,0 ml).
Each container delivers a minimum of 20 doses (6.5 ml) or 12 doses (5.0 ml).
Hver blød kapsel indeholder 150 mg nintedanib (som esilat).
Each soft capsule contains 150 mg nintedanib (as esilate).
Hver blød kapsel indeholder 20 mg tafamidismeglumin svarende til 12,2 mg tafamidis.
Each soft capsule contains 20 mg tafamidis meglumine equivalent to 12.2 mg tafamidis.
Hver blød kapsel indeholder 20 mg tafamidismeglumin svarende til 12,2 mg tafamidis.
Each soft capsule contains 20mg tafamidis meglumine equivalent to 12.2 mg tafamidis
Hver Brilique filmovertrukken tablet indeholder 60 mg ticagrelor.
Each film-coated tablet contains 60 mg of ticagrelor.
Hver Brilique filmovertrukken tablet indeholder 90 mg ticagrelor.
Each film-coated tablet contains 90 mg of ticagrelor.
Hver Budesonid/Formoterol Teva inhalator indeholder 120 inhalationer og har en hvid hoveddel med et halvgennemsigtigt, vinrødt låg til mundstykket.
Each Budesonide/Formoterol Teva inhaler contains 120 inhalations and has a white body with a semi- transparent wine red mouthpiece cover.
Hver Budesonid/Formoterol Teva inhalator indeholder 60 inhalationer og har en hvid hoveddel med et halvgennemsigtigt, vinrødt låg til mundstykket.
Each Budesonide/Formoterol Teva inhaler contains 60 inhalations and has a white body with a semi- transparent wine red mouthpiece cover.
Hver Budesonid/Formoterol Teva Pharma B.V. inhalator indeholder 120 inhalationer og har en hvid hoveddel med et halvgennemsigtigt, vinrødt låg til mundstykket.
Each Budesonide/Formoterol Teva Pharma B.V. inhaler contains 120 inhalations and has a white body with a semi-transparent wine red mouthpiece cover.
Hver Budesonid/Formoterol Teva Pharma B.V. inhalator indeholder 60 inhalationer og har en hvid hoveddel med et halvgennemsigtigt, vinrødt låg til mundstykket.
Each Budesonide/Formoterol Teva Pharma B.V. inhaler contains 60 inhalations and has a white body with a semi-transparent wine red mouthpiece cover.
Hver bukkaltablet indeholder 100 mikrogram fentanyl (som citrat)
Each buccal tablet contains 100 micrograms fentanyl (as citrate)
Hver bukkaltablet indeholder 100 mikrogram fentanyl (som citrat).
Each buccal tablet contains 100 micrograms fentanyl (as citrate).
Hver bukkaltablet indeholder 200 mikrogram fentanyl (som citrat)
Each buccal tablet contains 200 micrograms fentanyl (as citrate)
Hver bukkaltablet indeholder 200 mikrogram fentanyl (som citrat).
Each buccal tablet contains 200 micrograms fentanyl (as citrate).
Hver bukkaltablet indeholder 400 mikrogram fentanyl (som citrat)
Each buccal tablet contains 400 micrograms fentanyl (as citrate)
Hver bukkaltablet indeholder 400 mikrogram fentanyl (som citrat).
Each buccal tablet contains 400 micrograms fentanyl (as citrate).
Hver bukkaltablet indeholder 600 mikrogram fentanyl (som citrat)
Each buccal tablet contains 600 micrograms fentanyl (as citrate)
Hver bukkaltablet indeholder 600 mikrogram fentanyl (som citrat).
Each buccal tablet contains 600 micrograms fentanyl (as citrate).
Hver bukkaltablet indeholder 800 mikrogram fentanyl (som citrat).
Each buccal tablet contains 800 micrograms fentanyl (as citrate).
Hver Clomicalm tablet indeholder:
Each tablet of Clomicalm contains:
Hver Corbilta 100 mg/25 mg/200 mg tablet indeholder 100 mg levodopa, 25 mg carbidopa og 200 mg entacapon.
Each Corbilta 100 mg/25 mg/200 mg tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.
Hver Corbilta 125 mg/31,25 mg/200 mg tablet indeholder 125 mg levodopa, 31,25 mg carbidopa og 200 mg entacapon.
Each Corbilta 125 mg/31.25 mg/200 mg tablet contains 125 mg of levodopa, 31.25 mg of carbidopa and 200 mg of entacapone.
Hver Corbilta 150 mg/37,5 mg/200 mg tablet indeholder 150 mg levodopa, 37,5 mg carbidopa og 200 mg entacapon.
Each Corbilta 150 mg/37.5 mg/200 mg tablet contains 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone.
Hver Corbilta 175 mg/43,75 mg/200 mg tablet indeholder 175 mg levodopa, 43,75 mg carbidopa og 200 mg entacapon.
Each Corbilta 175 mg/43.75 mg/200 mg tablet contains 175 mg of levodopa, 43.75 mg of carbidopa and 200 mg of entacapone.
Hver Corbilta 200 mg/50 mg/200 mg tablet indeholder 200 mg levodopa, 50 mg carbidopa og 200 mg entacapon.
Each Corbilta 200 mg/50 mg/200 mg tablet contains 200 mg of levodopa, 50 mg of carbidopa and 200 mg of entacapone.
Hver Corbilta 50 mg/12,5 mg/200 mg tablet indeholder 50 mg levodopa, 12,5 mg carbidopa og 200 mg entacapon.
Each Corbilta 50 mg/12.5 mg/200 mg tablet contains 50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.
Hver Corbilta 75 mg/18,75 mg/200 mg tablet indeholder 75 mg levodopa, 18,75 mg carbidopa og 200 mg entacapon.
Each Corbilta 75 mg/18.75 mg/200 mg tablet contains 75 mg of levodopa, 18.75 mg of carbidopa and 200 mg of entacapone.
Hver cyklus varer 28 dage (4 uger).
Each cycle lasts 28 days (4 weeks).
Hver cylindeampul indeholder 3 ml injektionsvæske, opløsning, svarende til 300 enheder.
Each cartridge contains 3 ml of solution for injection, equivalent to 300 Units.
Hver cylinderampul (3 ml) indeholder 300 enheder (E) insulin degludec/insulin aspart.
Each cartridge (3 mL) contains 300 units (U) of insulin degludec/insulin aspart.
Hver cylinderampul er monteret i en plastinjektor af pennetypen (injektionspen) til engangsbrug.
Each cartridge is assembled into a disposable single use plastic pen injector (pen).
Hver cylinderampul indeholder 132 mikrogram, svarende til 36 millioner Internationale Enheder (IE) interferon beta-1a.
Each cartridge contains 132 micrograms corresponding to 36 million International Units (IU) of interferon beta-1a.
Hver cylinderampul indeholder 132 mikrogram, svarende til 36 millioner Internationale Enheder (IE), interferon beta-1a.
Each cartridge contains 132 micrograms corresponding to 36 million International Units (IU) of interferon beta-1a.
Hver cylinderampul indeholder 3 kugler (rustfrit stål)
Each cartridge contains 3 balls (stainless steel).
Hver cylinderampul indeholder 3 metalkugler (rustfrit stål).
Each cartridge contains 3 balls (stainless steel).
Hver cylinderampul indeholder 3 ml injektionsvæske, opløsning (svarende til 300 enheder) og findes i pakninger a 1, 2, 5, 10 og en flerstykspakning med 2 x 5 cylinderampuller.
Each cartridge contains 3 mL of solution for injection (equivalent to 300 units) and they are available in packs of 1, 2, 5, 10 and a multipack with 2 x 5 cartridges.
Hver cylinderampul indeholder 3 ml svarende til 300 E insulin lispro.
Each container includes 3ml equivalent to 300U insulin lispro.
Hver cylinderampul indeholder 3 ml svarende til 300 enheder insulin lispro.
Each container includes 3ml equivalent to 300 units insulin lispro.
Hver cylinderampul indeholder 300 enheder (3 milliliter).
Each cartridge contains 300 units (3 millilitres).
Hver cylinderampul indeholder 300 enheder insulin aspart i 3 ml injektionsvæske, suspension
Each cartridge contains 300 units of insulin aspart in 3 ml suspension for injection.
Hver cylinderampul indeholder 300 IE (svarende til 22 mikrogram) follitropin alfa i 0,5 ml injektionsvæske, opløsning.
Each cartridge contains 300 IU (equivalent to 22 micrograms) follitropin alfa in 0.5 mL solution for injection.
Hver cylinderampul indeholder 300 IE (svarende til 22 mikrogram) follitropin alfa i 0,5 ml opløsning.
Each cartridge contains 300 IU (equivalent to 22 micrograms) follitropin alfa in 0.5 mL solution.
Hver cylinderampul indeholder 300 internatinale enheder humant insulin i 3 ml injektionsvæske, suspension.
Each cartridge contains 300 international units of human insulin in 3 ml suspension for injection.
Hver cylinderampul indeholder 300 internationale enheder humant insulin i 3 ml injektionsvæske, opløsning.
Each cartridge contains 300 international units of human insulin in 3 ml solution for injection.
Hver cylinderampul indeholder 300 internationale enheder humant insulin i 3 ml injektionsvæske, suspension.
Each cartridge contains 300 international units of human insulin in 3 ml suspension for injection.
Hver cylinderampul indeholder 450 IE (svarende til 33 mikrogram) follitropin alfa i 0,75 ml injektionsvæske, opløsning.
Each cartridge contains 450 IU (equivalent to 33 micrograms) follitropin alfa in 0.75 mL solution for injection.
Hver cylinderampul indeholder 450 IE (svarende til 33 mikrogram) follitropin alfa i 0,75 ml opløsning.
Each cartridge contains 450 IU (equivalent to 33 micrograms) follitropin alfa in 0.75 mL solution.
Hver cylinderampul indeholder 66 mikrogram, svarende til 18 millioner Internationale Enheder (IE) interferon beta-1a.
Each cartridge contains 66 micrograms corresponding to 18 million International Units (IU) of interferon beta-1a.
Hver cylinderampul indeholder 900 IE (svarende til 66 mikrogram) follitropin alfa i 1,5 ml injektionsvæske, opløsning.
Each cartridge contains 900 IU (equivalent to 66 micrograms) follitropin alfa in 1.5 mL solution for injection.
Hver cylinderampul indeholder 900 IE (svarende til 66 mikrogram) follitropin alfa i 1,5 ml opløsning.
Each cartridge contains 900 IU (equivalent to 66 micrograms) follitropin alfa in 1.5 mL solution.
Hver cylinderampul indeholder det aktive stof follitropin beta, et hormon kendt som follikelstimulerende hormon (FSH), i en styrke på 833 IE i 1,0 ml vandig opløsning.
Each cartridge contains the active substance follitropin beta, a hormone known as follicle- stimulating hormone (FSH) in a strength of 833 IU/mL aqueous solution.
Hver cylinderampul indeholder det aktive stof follitropin beta, et hormon kendt som follikelstimulerende hormon (FSH), i en styrke på 833 IE i 1,0 ml vandig opløsning.
Each cartridge contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH) in a strength of 833 IU/mL aqueous solution.
Hver cylinderampul injektionsvæske, suspension indeholder 3 ml svarende til 300 IE insulin.
Each cartridge contains 3 ml of suspension for injection, equivalent to 300 IU insulin.
Hver Cymbalta kapsel indeholder pellets af det aktive stof med en belægning, som beskytter dem mod mavesyre.
Each capsule of Cymbalta contains pellets of duloxetine hydrochloride with a covering to protect them from stomach acid.
Hver dag skal beholderen tages fra den nummererede plads, der passer til kalenderdagen, for at sikre, at ingen dagsdosis springes over.
Each day, the vial should be taken from the numbered spot that matches the calendar day to make sure a daily dose is not missed.
Hver delestreg svarer til 0,1 ml.
Each graduation ring corresponds to a volume of 0.1 ml.
Hver delestreg svarer til et volumen på 0,1 ml.
Each graduation ring corresponds to a volume of 0.1 ml.
Hver depottablet indeholder 1,5 mg paliperidon.
Each prolonged-release tablet contains 1.5 mg of paliperidone.
Hver depottablet indeholder 1,5 mg paliperidon.
Each prolonged-release tablet contains 1.5 mg paliperidone
Hver depottablet indeholder 10 mg fampridin
Each prolonged-release tablet contains 10 mg of fampridine
Hver depottablet indeholder 100 mg eller 50 mg nevirapin.
Each prolonged-release tablet contains 100 mg or 50 mg nevirapine.
Hver depottablet indeholder 12 mg paliperidon.
Each prolonged-release tablet contains 12 mg paliperidone
Hver depottablet indeholder 3 mg paliperidon.
Each prolonged-release tablet contains 3 mg paliperidone
Hver depottablet indeholder 3 mg pramipexol dihydrochloridmonohydrat svarende til 2,1 mg pramipexol.
Each prolonged-release tablet contains 3 mg pramipexole dihydrochloride monohydrate equivalent to
Hver depottablet indeholder 375 mg ranolazin.
Each prolonged-release tablet contains 375 mg ranolazine.
Hver depottablet indeholder 500 mg ranolazin.
Each prolonged-release tablet contains 500 mg ranolazine.
Hver depottablet indeholder 6 mg paliperidon.
Each prolonged-release tablet contains 6 mg paliperidone